Cummings JL

References (46)

Title : Treatment Combinations for Alzheimer's Disease: Current and Future Pharmacotherapy Options - Cummings_2019_J.Alzheimers.Dis_67_779
Author(s) : Cummings JL , Tong G , Ballard C
Ref : J Alzheimers Dis , 67 :779 , 2019
Abstract :
PubMedSearch : Cummings_2019_J.Alzheimers.Dis_67_779
PubMedID: 30689575

Title : Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program - Cummings_2018_Alzheimers.Res.Ther_10_116
Author(s) : Cummings JL , Atri A , Ballard C , Boneva N , Frolich L , Molinuevo JL , Raket LL , Tariot PN
Ref : Alzheimers Res Ther , 10 :116 , 2018
Abstract :
PubMedSearch : Cummings_2018_Alzheimers.Res.Ther_10_116
PubMedID: 30474567

Title : Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials - Atri_2018_JAMA_319_130
Author(s) : Atri A , Frolich L , Ballard C , Tariot PN , Molinuevo JL , Boneva N , Windfeld K , Raket LL , Cummings JL
Ref : Jama , 319 :130 , 2018
Abstract :
PubMedSearch : Atri_2018_JAMA_319_130
PubMedID: 29318278

Title : Tolerability of ORM-12741 and effects on episodic memory in patients with Alzheimer's disease - Rinne_2017_Alzheimers.Dement.(N.Y)_3_1
Author(s) : Rinne JO , Wesnes K , Cummings JL , Hakulinen P , Hallikainen M , Hanninen J , Murphy M , Riordan H , Scheinin M , Soininen H , Rouru J
Ref : Alzheimers Dement (N Y) , 3 :1 , 2017
Abstract :
PubMedSearch : Rinne_2017_Alzheimers.Dement.(N.Y)_3_1
PubMedID: 29067315

Title : A practical algorithm for managing Alzheimer's disease: what, when, and why? - Cummings_2015_Ann.Clin.Transl.Neurol_2_307
Author(s) : Cummings JL , Isaacson RS , Schmitt FA , Velting DM
Ref : Ann Clin Transl Neurol , 2 :307 , 2015
Abstract :
PubMedSearch : Cummings_2015_Ann.Clin.Transl.Neurol_2_307
PubMedID: 25815358

Title : Alzheimer's disease drug-development pipeline: few candidates, frequent failures - Cummings_2014_Alzheimers.Res.Ther_6_37
Author(s) : Cummings JL , Morstorf T , Zhong K
Ref : Alzheimers Res Ther , 6 :37 , 2014
Abstract :
PubMedSearch : Cummings_2014_Alzheimers.Res.Ther_6_37
PubMedID: 25024750

Title : Reviewing the role of donepezil in the treatment of Alzheimer's disease - Doody_2012_Curr.Alzheimer.Res_9_773
Author(s) : Doody RS , Cummings JL , Farlow MR
Ref : Curr Alzheimer Res , 9 :773 , 2012
Abstract :
PubMedSearch : Doody_2012_Curr.Alzheimer.Res_9_773
PubMedID: 22175653

Title : Effects of oral rivastigmine on cognitive domains in mild-to-moderate Alzheimer's disease - Farlow_2010_Am.J.Alzheimers.Dis.Other.Demen_25_347
Author(s) : Farlow MR , Cummings JL , Olin JT , Meng X
Ref : Am J Alzheimers Dis Other Demen , 25 :347 , 2010
Abstract :
PubMedSearch : Farlow_2010_Am.J.Alzheimers.Dis.Other.Demen_25_347
PubMedID: 20392862

Title : Behavioral effects of current Alzheimer's disease treatments: a descriptive review - Cummings_2008_Alzheimers.Dement_4_49
Author(s) : Cummings JL , Mackell J , Kaufer D
Ref : Alzheimers Dement , 4 :49 , 2008
Abstract :
PubMedSearch : Cummings_2008_Alzheimers.Dement_4_49
PubMedID: 18631950

Title : Relative tolerability of Alzheimer's disease treatments - Alva_2008_Psychiatry.(Edgmont)_5_27
Author(s) : Alva G , Cummings JL
Ref : Psychiatry (Edgmont) , 5 :27 , 2008
Abstract :
PubMedSearch : Alva_2008_Psychiatry.(Edgmont)_5_27
PubMedID: 19724715

Title : Treatment of Alzheimer's disease: the role of symptomatic agents in an era of disease-modifying therapies - Cummings_2007_Rev.Neurol.Dis_4_57
Author(s) : Cummings JL
Ref : Rev Neurol Dis , 4 :57 , 2007
Abstract :
PubMedSearch : Cummings_2007_Rev.Neurol.Dis_4_57
PubMedID: 17609636

Title : Effective pharmacologic management of Alzheimer's disease - Farlow_2007_Am.J.Med_120_388
Author(s) : Farlow MR , Cummings JL
Ref : American Journal of Medicine , 120 :388 , 2007
Abstract :
PubMedSearch : Farlow_2007_Am.J.Med_120_388
PubMedID: 17466645

Title : Current and emerging pharmacological treatment options for dementia - Ringman_2006_Behav.Neurol_17_5
Author(s) : Ringman JM , Cummings JL
Ref : Behav Neurol , 17 :5 , 2006
Abstract :
PubMedSearch : Ringman_2006_Behav.Neurol_17_5
PubMedID: 16720956

Title : Effects of donepezil on neuropsychiatric symptoms in patients with dementia and severe behavioral disorders - Cummings_2006_Am.J.Geriatr.Psychiatry_14_605
Author(s) : Cummings JL , McRae T , Zhang R
Ref : American Journal of Geriatry & Psychiatry , 14 :605 , 2006
Abstract :
PubMedSearch : Cummings_2006_Am.J.Geriatr.Psychiatry_14_605
PubMedID: 16816014

Title : Metabolic patterns associated with the clinical response to galantamine therapy: a fludeoxyglucose f 18 positron emission tomographic study - Mega_2005_Arch.Neurol_62_721
Author(s) : Mega MS , Dinov ID , Porter V , Chow G , Reback E , Davoodi P , O'Connor SM , Carter MF , Amezcua H , Cummings JL
Ref : Archives of Neurology , 62 :721 , 2005
Abstract :
PubMedSearch : Mega_2005_Arch.Neurol_62_721
PubMedID: 15883258

Title : Cholinesterase inhibitors for treatment of dementia associated with Parkinson's disease -
Author(s) : Cummings JL
Ref : Journal of Neurology Neurosurg Psychiatry , 76 :903 , 2005
PubMedID: 15965192

Title : Searching for methods to detect, prevent, and treat Alzheimer's disease -
Author(s) : Cummings JL
Ref : Am J Psychiatry , 162 :645 , 2005
PubMedID: 15800132

Title : Behavioral and neuropsychiatric outcomes in Alzheimer's disease - Cummings_2005_CNS.Spectr_10_22
Author(s) : Cummings JL
Ref : CNS Spectr , 10 :22 , 2005
Abstract :
PubMedSearch : Cummings_2005_CNS.Spectr_10_22
PubMedID: 16273027

Title : Alzheimer's disease -
Author(s) : Cummings JL
Ref : N Engl J Med , 351 :56 , 2004
PubMedID: 15229308

Title : Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer's disease - Wynn_2004_Dement.Geriatr.Cogn.Disord_17_100
Author(s) : Wynn ZJ , Cummings JL
Ref : Dementia & Geriatric Cognitive Disorders , 17 :100 , 2004
Abstract :
PubMedSearch : Wynn_2004_Dement.Geriatr.Cogn.Disord_17_100
PubMedID: 14564129

Title : Reduction of behavioral disturbances and caregiver distress by galantamine in patients with Alzheimer's disease - Cummings_2004_Am.J.Psychiatry_161_532
Author(s) : Cummings JL , Schneider L , Tariot PN , Kershaw PR , Yuan W
Ref : Am J Psychiatry , 161 :532 , 2004
Abstract :
PubMedSearch : Cummings_2004_Am.J.Psychiatry_161_532
PubMedID: 14992980

Title : Treatment of Alzheimer's disease: current and future therapeutic approaches - Cummings_2004_Rev.Neurol.Dis_1_60
Author(s) : Cummings JL
Ref : Rev Neurol Dis , 1 :60 , 2004
Abstract :
PubMedSearch : Cummings_2004_Rev.Neurol.Dis_1_60
PubMedID: 16400259

Title : Cholinesterase inhibitors in non-Alzheimer dementias -
Author(s) : Gustavson AR , Cummings JL
Ref : J Am Med Dir Assoc , 4 :S165 , 2003
PubMedID: 14613594

Title : Use of cholinesterase inhibitors in clinical practice: evidence-based recommendations - Cummings_2003_Am.J.Geriatr.Psychiatry_11_131
Author(s) : Cummings JL
Ref : American Journal of Geriatry & Psychiatry , 11 :131 , 2003
Abstract :
PubMedSearch : Cummings_2003_Am.J.Geriatr.Psychiatry_11_131
PubMedID: 12611743

Title : Guidelines for managing Alzheimer's disease: Part II. Treatment - Cummings_2002_Am.Fam.Physician_65_2525
Author(s) : Cummings JL , Frank JC , Cherry D , Kohatsu ND , Kemp B , Hewett L , Mittman B
Ref : Am Fam Physician , 65 :2525 , 2002
Abstract :
PubMedSearch : Cummings_2002_Am.Fam.Physician_65_2525
PubMedID: 12086242

Title : Benefit-risk considerations in the treatment of dementia with Lewy bodies - Swanberg_2002_Drug.Saf_25_511
Author(s) : Swanberg MM , Cummings JL
Ref : Drug Safety , 25 :511 , 2002
Abstract :
PubMedSearch : Swanberg_2002_Drug.Saf_25_511
PubMedID: 12093309

Title : Neuropsychiatric symptoms in the dementias - Assal_2002_Curr.Opin.Neurol_15_445
Author(s) : Assal F , Cummings JL
Ref : Curr Opin Neurol , 15 :445 , 2002
Abstract :
PubMedSearch : Assal_2002_Curr.Opin.Neurol_15_445
PubMedID: 12151841

Title : Treatment of Alzheimer's disease - Cummings_2001_Clin.Cornerstone_3_27
Author(s) : Cummings JL
Ref : Clin Cornerstone , 3 :27 , 2001
Abstract :
PubMedSearch : Cummings_2001_Clin.Cornerstone_3_27
PubMedID: 11432120

Title : Efficacy of metrifonate in improving the psychiatric and behavioral disturbances of patients with Alzheimer's disease - Cummings_2001_J.Geriatr.Psychiatry.Neurol_14_101
Author(s) : Cummings JL , Nadel A , Masterman D , Cyrus PA
Ref : J Geriatr Psychiatry Neurol , 14 :101 , 2001
Abstract :
PubMedSearch : Cummings_2001_J.Geriatr.Psychiatry.Neurol_14_101
PubMedID: 11419566

Title : Practice parameter: management of dementia (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology - Doody_2001_Neurology_56_1154
Author(s) : Doody RS , Stevens JC , Beck C , Dubinsky RM , Kaye JA , Gwyther L , Mohs RC , Thal LJ , Whitehouse PJ , DeKosky ST , Cummings JL
Ref : Neurology , 56 :1154 , 2001
Abstract :
PubMedSearch : Doody_2001_Neurology_56_1154
PubMedID: 11342679

Title : A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting - Tariot_2001_J.Am.Geriatr.Soc_49_1590
Author(s) : Tariot PN , Cummings JL , Katz IR , Mintzer J , Perdomo CA , Schwam EM , Whalen E
Ref : J Am Geriatr Soc , 49 :1590 , 2001
Abstract :
PubMedSearch : Tariot_2001_J.Am.Geriatr.Soc_49_1590
PubMedID: 11843990

Title : Cognitive and metabolic responses to metrifonate therapy in Alzheimer disease - Mega_2001_Neuropsychiatry.Neuropsychol.Behav.Neurol_14_63
Author(s) : Mega MS , Cummings JL , O'Connor SM , Dinov ID , Reback E , Felix J , Masterman DL , Phelps ME , Small GW , Toga AW
Ref : Neuropsychiatry Neuropsychol Behav Neurol , 14 :63 , 2001
Abstract :
PubMedSearch : Mega_2001_Neuropsychiatry.Neuropsychol.Behav.Neurol_14_63
PubMedID: 11234910

Title : Neuropsychiatric assessment of Alzheimer's disease and related dementias - Cummings_2001_Aging.(Milano)_13_240
Author(s) : Cummings JL , McPherson S
Ref : Aging (Milano) , 13 :240 , 2001
Abstract :
PubMedSearch : Cummings_2001_Aging.(Milano)_13_240
PubMedID: 11444257

Title : Cholinesterase inhibitors: A new class of psychotropic compounds - Cummings_2000_Am.J.Psychiatry_157_4
Author(s) : Cummings JL
Ref : Am J Psychiatry , 157 :4 , 2000
Abstract :
PubMedSearch : Cummings_2000_Am.J.Psychiatry_157_4
PubMedID: 10618007

Title : The relationship between donepezil and behavioral disturbances in patients with Alzheimer's disease - Cummings_2000_Am.J.Geriatr.Psychiatry_8_134
Author(s) : Cummings JL , Donohue JA , Brooks RL
Ref : American Journal of Geriatry & Psychiatry , 8 :134 , 2000
Abstract :
PubMedSearch : Cummings_2000_Am.J.Geriatr.Psychiatry_8_134
PubMedID: 10804074

Title : Orbital and dorsolateral frontal perfusion defect associated with behavioral response to cholinesterase inhibitor therapy in Alzheimer's disease - Mega_2000_J.Neuropsychiatry.Clin.Neurosci_12_209
Author(s) : Mega MS , Dinov ID , Lee L , O'Connor SM , Masterman DM , Wilen B , Mishkin F , Toga AW , Cummings JL
Ref : J Neuropsychiatry Clin Neurosci , 12 :209 , 2000
Abstract :
PubMedSearch : Mega_2000_J.Neuropsychiatry.Clin.Neurosci_12_209
PubMedID: 11001599

Title : Cholinesterase inhibitors: expanding applications -
Author(s) : Cummings JL
Ref : Lancet , 356 :2024 , 2000
PubMedID: 11145482

Title : The spectrum of behavioral responses to cholinesterase inhibitor therapy in Alzheimer disease - Mega_1999_Arch.Neurol_56_1388
Author(s) : Mega MS , Masterman DM , O'Connor SM , Barclay TR , Cummings JL
Ref : Archives of Neurology , 56 :1388 , 1999
Abstract :
PubMedSearch : Mega_1999_Arch.Neurol_56_1388
PubMedID: 10555660

Title : Neuropsychiatric Symptoms and Cholinergic Therapy for Alzheimer's Disease - Levy_1999_Gerontology_45_15
Author(s) : Levy ML , Cummings JL , Kahn-Rose R
Ref : Gerontology , 45 :15 , 1999
Abstract :
PubMedSearch : Levy_1999_Gerontology_45_15
PubMedID: 9876214

Title : Metrifonate (Trichlorfon): a review of the pharmacology, pharmacokinetics and clinical experience with a new acetylcholinesterase inhibitor for Alzheimer's disease - Ringman_1999_Expert.Opin.Investig.Drugs_8_463
Author(s) : Ringman JM , Cummings JL
Ref : Expert Opin Investig Drugs , 8 :463 , 1999
Abstract :
PubMedSearch : Ringman_1999_Expert.Opin.Investig.Drugs_8_463
PubMedID: 15992092

Title : Metrifonate: update on a new antidementia agent - Ringman_1999_J.Clin.Psychiatry_60_776
Author(s) : Ringman JM , Cummings JL
Ref : J Clin Psychiatry , 60 :776 , 1999
Abstract :
PubMedSearch : Ringman_1999_J.Clin.Psychiatry_60_776
PubMedID: 10584768

Title : Metrifonate: overview of safety and efficacy - Cummings_1998_Pharmacotherapy_18_43
Author(s) : Cummings JL
Ref : Pharmacotherapy , 18 :43 , 1998
Abstract :
PubMedSearch : Cummings_1998_Pharmacotherapy_18_43
PubMedID: 9543464

Title : Drug treatment for Alzheimer's disease -
Author(s) : Tom T , Cummings JL
Ref : West J Med , 168 :264 , 1998
PubMedID: 9584667

Title : Metrifonate treatment of the cognitive deficits of Alzheimer's disease. Metrifonate Study Group [see comments] [published erratum appears in Neurology 1998 Jul\;51(1):332] - Cummings_1998_Neurology_50_1214
Author(s) : Cummings JL , Cyrus PA , Bieber F , Mas J , Orazem J , Gulanski B
Ref : Neurology , 50 :1214 , 1998
Abstract :
PubMedSearch : Cummings_1998_Neurology_50_1214
PubMedID: 9595966

Title : Differential neuropsychiatric symptom responses to tacrine in Alzheimer's disease: relationship to dementia severity - Kaufer_1998_J.Neuropsychiatry.Clin.Neurosci_10_55
Author(s) : Kaufer D , Cummings JL , Christine D
Ref : J Neuropsychiatry Clin Neurosci , 10 :55 , 1998
Abstract :
PubMedSearch : Kaufer_1998_J.Neuropsychiatry.Clin.Neurosci_10_55
PubMedID: 9547467

Title : Effect of tacrine on behavioral symptoms in Alzheimer's disease: an open-label study - Kaufer_1996_J.Geriatr.Psychiatry.Neurol_9_1
Author(s) : Kaufer DI , Cummings JL , Christine D
Ref : J Geriatr Psychiatry Neurol , 9 :1 , 1996
Abstract :
PubMedSearch : Kaufer_1996_J.Geriatr.Psychiatry.Neurol_9_1
PubMedID: 8679057